Lab
Advanta Labs, LLC
Advanta Labs, LLC was paid $39K by Medicaid between Jan 2018 and Sep 2021, across 27 billing codes. Its largest line is 81161, — 36% of everything it billed.
33Billing provider infoADVANTA LABS, LLC
SOUTHLAKE, TX 76092
SOUTHLAKE, TX 76092
33aNPI1801212766assigned 03/14/2014
33bProvider typeClinical Medical Laboratory
28Total paid$39K
24GClaims6,281
24DCodes billed27
24AFirst – last monthJan 2018 – Sep 2021
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#195 of 436
Median peer was paid$17K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 306 | $0.00 | |
| 2020 | 520 | $0.00 | |
| 2021 | 5,455 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81161 | 36% | 198 | 153 | $14K | |
| 81404 | 23% | 1,673 | 297 | $9K | |
| 81252 | 13% | 99 | 69 | $5K | |
| 81401 | 9.5% | 278 | 198 | $4K | |
| 81225 | 7.6% | 41 | 29 | $3K | |
| 81407 | 3.0% | 399 | 266 | $1K | |
| 81405 | 2.1% | 840 | 300 | $833.30 | |
| 81406 | 2.0% | 853 | 300 | $782.22 | |
| 81413 | 1.7% | 197 | 152 | $646.95 | |
| 81414 | 1.7% | 142 | 113 | $646.95 | |
| 81227 | <1% | 43 | 29 | $148.91 | |
| 81238 | 0% | 159 | 122 | $0.00 |
15 more codes
| 81411 | 0% | 166 | $0.00 | |
| 81328 | 0% | 42 | $0.00 | |
| 81355 | 0% | 43 | $0.00 | |
| 81335 | 0% | 19 | $0.00 | |
| 81408 | 0% | 61 | $0.00 | |
| 81403 | 0% | 274 | $0.00 | |
| 81291 | 0% | 43 | $0.00 | |
| 81241 | 0% | 40 | $0.00 | |
| 81325 | 0% | 99 | $0.00 | |
| 81324 | 0% | 99 | $0.00 | |
| 81226 | 0% | 43 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 306 | $0.00 |
| 81240 | 0% | 40 | $0.00 | |
| 81230 | 0% | 42 | $0.00 | |
| 81231 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHADIAN, YUSUF (AUTHORIZED OFFICIAL)